Thymoquinone inhibits proliferation and impairs wound closure dynamics via apoptosis and autophagy-related pathways in multiple cancer cell lines
- 22 May 2026
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 814
Abstract
Background Thymoquinone (TQ), the principal bioactive component of Nigella sativa, has attracted considerable attention for its potential anticancer properties. However, its antiproliferative effects and the underlying molecular mechanisms across different cancer cell types remain incompletely understood. Methods This study aimed to investigate the cytotoxic, antiproliferative, and antimigratory effects of TQ and to elucidate its role in apoptosis- and autophagy-related pathways in multiple cancer cell lines. Human liver (Hep3B), lung (A549), neuroblastoma (SH-SY5Y), and breast cancer (MCF-7) cells were treated with TQ at concentrations of 1–200 µM for 24 and 48 h, while L929 fibroblast cells were used as a non-cancerous control. Cell viability was evaluated using the MTS assay, and wound closure, reflecting combined effects of cell migration and proliferation, was assessed using the wound healing assay. The expression levels of apoptosis- and autophagy-related genes (BAX, BCL2, CASP3, CASP8, CASP9, BECN1, SQSTM1, ATG5, and ATG7), as well as antiproliferative genes (TOB1, TOB2, BTG1, and BTG2), were analyzed by RT-PCR. Results TQ treatment significantly reduced cell viability in a dose- and time-dependent manner, with Hep3B and SH-SY5Y cells showing the highest sensitivity. Moreover, TQ markedly inhibited wound closure, particularly in Hep3B, A549, and MCF-7 cells. At the molecular level, TQ upregulated pro-apoptotic (BAX, CASPs) and autophagy-related (BECN1, ATG genes) markers while downregulating the anti-apoptotic gene BCL2. Additionally, the increased expression of TOB and BTG family genes supports their antiproliferative activity. Conclusions TQ exhibits broad-spectrum anticancer effects by suppressing proliferation and wound closure dynamics and inducing apoptosis and autophagy through gene regulatory mechanisms in a cell type-dependent manner. These findings provide mechanistic insights into the therapeutic potential of TQ in cancer treatment.Keywords
This publication has 40 references indexed in Scilit:
- Thymoquinone-conjugated liposomes improve cytotoxic and proapoptotic effects against hepatocellular cancer by altering the EGFR/ERK/MEK signaling axisDiscover Oncology, 2025
- Phytochemicals in Cancer Therapy: A Structured Review of Mechanisms, Challenges, and Progress in Personalized TreatmentChemistry & Biodiversity, 2025
- Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapyDiscover Oncology, 2025
- Low-dose rosmarinic acid and thymoquinone accelerate wound healing in retinal pigment epithelial cellsInternational Ophthalmology, 2023
- Thymoquinone induces apoptosis and protective autophagy in gastric cancer cells by inhibiting the PI3K/Akt/mTOR pathwayPhytotherapy Research, 2023
- Nerolidol attenuates dehydroepiandrosterone-induced polycystic ovary syndrome in rats by regulating oxidative stress and decreasing apoptosisLife Sciences, 2023
- Thymoquinone promotes mouse mesenchymal stem cells migration in vitro and induces their immunogenicity in vivoToxicology and Applied Pharmacology, 2020
- Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell linesMaterials Science and Engineering: C, 2019
- Thymoquinone‐induced antitumor and apoptosis in human lung adenocarcinoma cellsJournal of Cellular Physiology, 2018
- Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathwayTumor Biology, 2014